National Leaders in Vascular Care
The vascular program at NewYork-Presbyterian is home to the most innovative techniques available for complex aortic aneurysm repair and NYC’s only formal limb preservation program.
Hybrid Aortic Repair
Dr. Virendra Patel, NewYork-Presbyterian/Columbia, is one of the rare vascular surgeons who is highly skilled at both open and endovascular techniques for complex aortic aneurysm repair. His expertise allows procedures to be individually tailored to each patient’s specific aortic and vascular anatomy, avoiding additional risks and durable repairs. Columbia endovascular surgeons, cardiac surgeons, and interventionalists often perform surgeries together and participate in each other’s clinical trials.
Leaders in Limb Preservation
As the only formal limb preservation program in NYC, more than 5,000 patients visit our Program for Advanced Limb Preservation (PALP) annually. A collaborative effort led by Dr. Darren Schneider, NewYork-Presbyterian/Weill Cornell, PALP includes a dedicated limb wound preservation clinic and an annual CME course, with plans to expand the program nationally. At NewYork-Presbyterian/Columbia more than 15,000 patients per year are treated with a multidisciplinary, multisite approach for limb salvage.
NewYork-Presbyterian/Columbia University Aortic Center is one of 23 sites in the world participating in the STABALISE registry, an investigational technique for acute aortic dissection. The New York-Presbyterian/Columbia Aortic program is the only center in New York and one of 12 centers in the United States participating in the first available aortic arch branch device trial. This comprehensive multidisciplinary collaborative program with Dr. Patel as the PI is designed to manage complex disease in the aortic arch, thoracic aorta, and its branches.
NewYork-Presbyterian/Weill Cornell Medical Center reached an important milestone: The100th patient was treated with an investigational fenestrated and branched stent graft for a thoracoabdominal aortic aneurysm. As the only center in New York with an FDA investigational device exemption approved clinical trial, Dr. Darren Schneider is part of a nationwide collaborative research consortium, pooling data of more than 1,000 patients.
Our telehealth remote program monitoring is helping to reduce the risk for hospital readmissions as well as helping patients avoid travel for multiple consultations and office visits. Our physicians and clinical team participate in telehealth visits for wound care, second opinions, pre-op patient risk/benefit discussions, aortic aneurysm follow-ups, and surveillance visits.